Int J Med Sci
2019; 16(7):931-938.
doi:10.7150/ijms.32413 This issueCite
Research Paper
First-line Screening of OXPHOS Deficiencies Using Microscale Oxygraphy in Human Skin Fibroblasts: A Preliminary Study
Nicolas Germain1,2, Anne-Frédérique Dessein1,3, Jean-Claude Vienne3, Dries Dobbelaere4, Karine Mention4, Marie Joncquel3, Salim Dekiouk1, William Laine1, Jérome Kluza1*, Philippe Marchetti1,2✉*
1. Univ. Lille, Inserm, UMR-S 1172 - JPArc - Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer, F-59000 Lille, France 2. CHU Lille, Centre de Biologie-Pathologie Banque de Tissus, F-59000 Lille, France 3. CHU Lille, Centre de Biologie-Pathologie UF Métabolisme général, hormonal et maladies rares, F-59000 Lille, France 4. CHU Lille, Centre de Référence des maladies héréditaires du métabolisme, F-59000 Lille, France *JK and PM share co-seniorship of this paper
✉ Corresponding author: Prof. Philippe MARCHETTI, MD, PhD. INSERM UMR-S 1172 Faculté de Médecine Université de Lille 1, place Verdun F-59045 Lille Cedex France. Tel: 33-3-20 29 88 51 33-3-20 16 92 29 E-mail: philippe.marchettifr
Citation:
Germain N, Dessein AF, Vienne JC, Dobbelaere D, Mention K, Joncquel M, Dekiouk S, Laine W, Kluza J, Marchetti P. First-line Screening of OXPHOS Deficiencies Using Microscale Oxygraphy in Human Skin Fibroblasts: A Preliminary Study. Int J Med Sci 2019; 16(7):931-938. doi:10.7150/ijms.32413. https://www.medsci.org/v16p0931.htm
The diagnosis of mitochondrial diseases is a real challenge because of the vast clinical and genetic heterogeneity. Classically, the clinical examination and genetic analysis must be completed by several biochemical assays to confirm the diagnosis of mitochondrial disease. Here, we tested the validity of microscale XF technology in measuring oxygen consumption in human skin fibroblasts isolated from 5 pediatric patients with heterogeneous mitochondrial disorders. We first set up the protocol conditions to allow the determination of respiratory parameters including respiration associated with ATP production, proton leak, maximal respiration, and spare respiratory capacity with reproducibility and repeatability. Maximum respiration and spare capacity were the only parameters decreased in patients irrespective of the type of OXPHOS deficiency. These results were confirmed by high-resolution oxygraphy, the reference method to measure cellular respiration. Given the fact that microscale XF technology allows fast, automated and standardized measurements, we propose to use microscale oxygraphy among the first-line methods to screen OXPHOS deficiencies.
Germain, N., Dessein, A.F., Vienne, J.C., Dobbelaere, D., Mention, K., Joncquel, M., Dekiouk, S., Laine, W., Kluza, J., Marchetti, P. (2019). First-line Screening of OXPHOS Deficiencies Using Microscale Oxygraphy in Human Skin Fibroblasts: A Preliminary Study. International Journal of Medical Sciences, 16(7), 931-938. https://doi.org/10.7150/ijms.32413.
ACS
Germain, N.; Dessein, A.F.; Vienne, J.C.; Dobbelaere, D.; Mention, K.; Joncquel, M.; Dekiouk, S.; Laine, W.; Kluza, J.; Marchetti, P. First-line Screening of OXPHOS Deficiencies Using Microscale Oxygraphy in Human Skin Fibroblasts: A Preliminary Study. Int. J. Med. Sci. 2019, 16 (7), 931-938. DOI: 10.7150/ijms.32413.
NLM
Germain N, Dessein AF, Vienne JC, Dobbelaere D, Mention K, Joncquel M, Dekiouk S, Laine W, Kluza J, Marchetti P. First-line Screening of OXPHOS Deficiencies Using Microscale Oxygraphy in Human Skin Fibroblasts: A Preliminary Study. Int J Med Sci 2019; 16(7):931-938. doi:10.7150/ijms.32413. https://www.medsci.org/v16p0931.htm
CSE
Germain N, Dessein AF, Vienne JC, Dobbelaere D, Mention K, Joncquel M, Dekiouk S, Laine W, Kluza J, Marchetti P. 2019. First-line Screening of OXPHOS Deficiencies Using Microscale Oxygraphy in Human Skin Fibroblasts: A Preliminary Study. Int J Med Sci. 16(7):931-938.
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.